WO2014091490A3 - Diagnosis of autoimmune diseases using a specific antibody profile - Google Patents

Diagnosis of autoimmune diseases using a specific antibody profile Download PDF

Info

Publication number
WO2014091490A3
WO2014091490A3 PCT/IL2013/051027 IL2013051027W WO2014091490A3 WO 2014091490 A3 WO2014091490 A3 WO 2014091490A3 IL 2013051027 W IL2013051027 W IL 2013051027W WO 2014091490 A3 WO2014091490 A3 WO 2014091490A3
Authority
WO
WIPO (PCT)
Prior art keywords
specific antibody
diagnosis
autoimmune diseases
antibody profile
scleroderma
Prior art date
Application number
PCT/IL2013/051027
Other languages
French (fr)
Other versions
WO2014091490A2 (en
Inventor
Irun R. Cohen
Eytan Domany
Ittai Fattal
Noam Shental
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Priority to US14/652,425 priority Critical patent/US20160069896A1/en
Priority to EP13829075.4A priority patent/EP2932271A2/en
Priority to CA2888880A priority patent/CA2888880A1/en
Priority to JP2015547272A priority patent/JP2016502095A/en
Publication of WO2014091490A2 publication Critical patent/WO2014091490A2/en
Publication of WO2014091490A3 publication Critical patent/WO2014091490A3/en
Priority to IL239464A priority patent/IL239464A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Methods and kits for diagnosing systemic lupus erythematosus (SLE) or scleroderma in a subject are provided. Particularly, the present invention relates to a specific antibody reactivity profile useful in diagnosing SLE or scleroderma in a subject.
PCT/IL2013/051027 2012-12-16 2013-12-16 Diagnosis of autoimmune diseases using a specific antibody profile WO2014091490A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US14/652,425 US20160069896A1 (en) 2012-12-16 2013-12-16 Diagnosis of autoimmune diseases using a specific antibody profile
EP13829075.4A EP2932271A2 (en) 2012-12-16 2013-12-16 Diagnosis of autoimmune diseases using a specific antibody profile
CA2888880A CA2888880A1 (en) 2012-12-16 2013-12-16 Diagnosis of autoimmune diseases using a specific antibody profile
JP2015547272A JP2016502095A (en) 2012-12-16 2013-12-16 Diagnosis of autoimmune diseases using specific antibody profiles
IL239464A IL239464A0 (en) 2012-12-16 2015-06-16 Diagnosis of autoimmune diseases using a specific antibody profile

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261737789P 2012-12-16 2012-12-16
US61/737,789 2012-12-16

Publications (2)

Publication Number Publication Date
WO2014091490A2 WO2014091490A2 (en) 2014-06-19
WO2014091490A3 true WO2014091490A3 (en) 2014-11-27

Family

ID=50102146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2013/051027 WO2014091490A2 (en) 2012-12-16 2013-12-16 Diagnosis of autoimmune diseases using a specific antibody profile

Country Status (5)

Country Link
US (1) US20160069896A1 (en)
EP (1) EP2932271A2 (en)
JP (1) JP2016502095A (en)
CA (1) CA2888880A1 (en)
WO (1) WO2014091490A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015101987A1 (en) 2013-12-31 2015-07-09 Yeda Research And Development Co. Ltd. Methods for assaying immunological competence
WO2015101988A1 (en) 2013-12-31 2015-07-09 Yeda Research And Development Co. Ltd. Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
WO2016139659A1 (en) 2015-03-01 2016-09-09 Immunarray Ltd. Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
CA3028975A1 (en) 2016-06-20 2017-12-28 Healthtell Inc. Methods for diagnosis and treatment of autoimmune diseases
AU2017281039A1 (en) * 2016-06-20 2019-01-24 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
US11371990B2 (en) 2016-11-11 2022-06-28 Cowper Sciences Inc. Methods for identifying candidate biomarkers
US11480568B2 (en) 2017-09-28 2022-10-25 Yeda Research And Development Co. Ltd. Diagnosis of autoimmune diseases
WO2022146869A1 (en) * 2020-12-29 2022-07-07 The Board Of Trustees Of The Leland Stanford Junior University Diagnostics and therapeutics for ebv in ms and other autoimmune diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1630557A1 (en) * 2004-08-27 2006-03-01 Institut Virion/Serion GmbH Diagnostic multiplexed bead assay for identification of antibodies against Epstein Barr Virus (EBV).
WO2011099012A1 (en) * 2010-02-12 2011-08-18 Yeda Research And Development Co. Ltd. Diagnosis of systemic lupus erythematosus (sle)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1630557A1 (en) * 2004-08-27 2006-03-01 Institut Virion/Serion GmbH Diagnostic multiplexed bead assay for identification of antibodies against Epstein Barr Virus (EBV).
WO2011099012A1 (en) * 2010-02-12 2011-08-18 Yeda Research And Development Co. Ltd. Diagnosis of systemic lupus erythematosus (sle)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAHAR ARTÄ+-M ESEN ET AL: "Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study", RHEUMATOLOGY INTERNATIONAL ; CLINICAL AND EXPERIMENTAL INVESTIGATIONS, SPRINGER, BERLIN, DE, vol. 32, no. 1, 27 July 2010 (2010-07-27), pages 79 - 83, XP019999309, ISSN: 1437-160X, DOI: 10.1007/S00296-010-1573-4 *
ITTAI FATTAL ET AL: "Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA", IMMUNOLOGY, vol. 141, no. 2, 9 February 2014 (2014-02-09), pages 276 - 285, XP055117374, ISSN: 0019-2805, DOI: 10.1111/imm.12200 *
Q-Z LI ET AL: "Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 147, no. 1, 1 January 2007 (2007-01-01), pages 60 - 70, XP002622508, ISSN: 0009-9104, [retrieved on 20061127], DOI: 10.1111/J.1365-2249.2006.03251.X *
TOUSSIROT ERIC ET AL: "Epstein-Barr virus in autoimmune diseases", BAILLIERE'S BEST PRACTICE AND RESEARCH. CLINICAL REUMATOLOGY, BAILLIERE TINDALL, LONDON, GB, vol. 22, no. 5, 1 October 2008 (2008-10-01), pages 883 - 896, XP002693832, ISSN: 1521-6942, DOI: 10.1016/J.BERH.2008.09.007 *

Also Published As

Publication number Publication date
CA2888880A1 (en) 2014-06-19
JP2016502095A (en) 2016-01-21
WO2014091490A2 (en) 2014-06-19
EP2932271A2 (en) 2015-10-21
US20160069896A1 (en) 2016-03-10

Similar Documents

Publication Publication Date Title
WO2014091490A3 (en) Diagnosis of autoimmune diseases using a specific antibody profile
WO2015061634A3 (en) Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders
WO2014189973A3 (en) Anti-transferrin receptor antibodies and methods of use
NZ700823A (en) Antibodies against claudin 18.2 useful in cancer diagnosis
WO2014160499A3 (en) Methods and compositions for detecting pancreatic cancer
WO2013096822A3 (en) Test device for optical and electrochemical assays
WO2014165771A3 (en) Anti-il-4 antibodies and bispecific antibodies and uses thereof
EP3176268A4 (en) Novel biomarker for predicting sensitivity to egfr-targeting agent, and use thereof
WO2012135340A3 (en) Compositions and methods for diagnosing cancer
WO2013153461A3 (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases
WO2015075269A9 (en) Antibodies against ccr9 and applications thereof
MX2015010174A (en) Diagnostic tools to predict onset of preeclampsia.
MX359442B (en) A method of scheduling a diagnostic event.
WO2012154983A3 (en) Systems and methods for anti-pax8 antibodies
EP2648105B8 (en) Database performance analysis
EP3285071A4 (en) Biomarker composition for diagnosing still's disease, diagnostic kit, and diagnostic method
WO2012154908A3 (en) Hairy cell leukemia biomarkers and methods of using same
HK1225798B (en) Use of a reagent for the lysis of erythrocytes as well as methods and kits relating thereto
MX2016001719A (en) Methods and kits for predicting the risk of having a cardiovascular disease or event.
AU2012339149A8 (en) Method for the diagnosis of Niemann-Pick disease
WO2013082249A3 (en) Compositions and methods for prostate cancer analysis
WO2012164525A3 (en) Aging biomarkers
EP3112867A4 (en) Qualitative predictive method for differential diagnosis of pneumococcic, meningococcic and viral menigitis, differential meningitis diagnostic method and kit
WO2014140911A3 (en) Diagnostic and therapeutic methods relating to microrna-144
WO2012076000A3 (en) Method for detecting anti-nmda receptor autoantibodies for use in diagnostic procedures

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13829075

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2888880

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2015547272

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 14652425

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 239464

Country of ref document: IL

REEP Request for entry into the european phase

Ref document number: 2013829075

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2013829075

Country of ref document: EP